Statistics from Altmetric.com
Contributors GR has written the commentary.
Competing interests GR has consulted to AbbVie, Augurix, Calypso, Celgene, FALK, Ferring, Essex/MSD, Genentech, Janssen, Lilly, Novartis, Pfizer, Roche, UCB, Takeda, Tillotts, Vifor and Zeller. GR has received speaker’s honoraria from AbbVie, FALK, Ferring, MSD, Pfizer, Phadia, Takeda, Tillotts, UCB and Vifor, and received educational grants and research grants from AbbVie, Ardeypharm, FALK, Flamentera, Novartis, MSD, Pfizer, Roche, Takeda, Tillotts, UCB and Zeller.
Patient consent Not required.
Provenance and peer review Commissioned; internally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.